119th Congress · introduced in the House · May 23, 2025
ANTE Act
Official title from Congress.gov
Latest action (May 23, 2025): Referred to the House Committee on Ways and Means.
View on Congress.govPolicy area: Foreign Trade and International Finance
Congressional Research Service summary, version: Introduced in House (May 23, 2025)
Axing Nonmarket Tariff Evasion Act or the ANTE Act
This bill authorizes the Office of the U.S. Trade Representative (USTR) to investigate and take remedial action against covered entities that evade or attempt to evade duties (i.e., tariffs) that were imposed on nonmarket economy countries (e.g., China) by investing in other countries.
Under the bill, a covered entity (e.g., business) (1) is owned, controlled, subject to the jurisdiction or direction of, or operated by a nonmarket economy country; and (2) includes an entity for which, on any date during the most recent 12-month period, at least 25% of the equity interests in such entity were held directly or indirectly by one or more entities organized under the laws of a nonmarket economy country.
Currently, Section 301 of the Trade Act of 1974 allows the USTR to impose tariffs in response to actions by foreign countries that violate U.S. rights under international trade agreements or that burden or restrict U.S. commerce in unjustifiable, unreasonable, or discriminatory ways. In 2018, for example, the USTR used Section 301 to impose tariffs on many imports from China.
This bill allows the USTR to investigate whether a covered entity is establishing or has established investments (e.g., manufacturing operations) in another country that is not subject to Section 301 tariffs in order to evade those tariffs. Upon an affirmative determination, the USTR may impose certain remedial measures, such as imposing a tariff equivalent to the original tariff on goods associated with the nonmarket economy country.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Ways and Means.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
6 citations.
NOVONIX ANODE MATERIALS LLC · lobbying firm or registrant: BRIDGE PUBLIC AFFAIRS, LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 14, 2026 · issue area: Trade (domestic/foreign)
$30,000
Paid to lobbying firm
Discussions related to 301 tariffs; H.R.3575/S.1886, Axing Nonmarket Tariff EvasionAct (ANTE Act).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NOVONIX ANODE MATERIALS LLC · lobbying firm or registrant: BRIDGE PUBLIC AFFAIRS, LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 17, 2026 · issue area: Trade (domestic/foreign)
$30,000
Paid to lobbying firm
Discussions related to 301 tariffs; H.R.3575/S.1886, Axing Nonmarket Tariff EvasionAct (ANTE Act).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NOVONIX ANODE MATERIALS LLC · lobbying firm or registrant: BRIDGE PUBLIC AFFAIRS, LLC
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 14, 2026 · issue area: Trade (domestic/foreign)
$30,000
Paid to lobbying firm
Discussions related to 301 tariffs; H.R.3575/S.1886, Axing Nonmarket Tariff EvasionAct (ANTE Act).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NOVONIX ANODE MATERIALS LLC · lobbying firm or registrant: BRIDGE PUBLIC AFFAIRS, LLC
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 16, 2025 · issue area: Trade (domestic/foreign)
$30,000
Paid to lobbying firm
Discussions related to 301 tariffs; H.R.3575/S.1886, Axing Nonmarket Tariff EvasionAct (ANTE Act).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CUMMINS INC · lobbying firm or registrant: CUMMINS, INC.
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 21, 2025 · issue area: Trade (domestic/foreign)
$521,879
Spent on own lobbying
…PA Tariffs- No Bill; 301 Tariffs- No Bill; 232 Tariffs- No Bill; USMCA review- No Bill; Trade Review Act of 2025 - HR.2665; Axing Nonmarket Tariff Evasion Act- H.R. 3575
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NOVONIX ANODE MATERIALS LLC · lobbying firm or registrant: BRIDGE PUBLIC AFFAIRS, LLC
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 19, 2025 · issue area: Trade (domestic/foreign)
$30,000
Paid to lobbying firm
Discussions related to 301 tariffs; H.R.3575/S.1886, Axing Nonmarket Tariff EvasionAct (ANTE Act).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing